Fasting-mimicking diet plus chemotherapy in breast cancer treatment

Claudio Vernieri; Francesca Ligorio; Emma Zattarin; Licia Rivoltini; Filippo de Braud

doi:10.1038/s41467-020-18194-1

Nature Communications (Aug 2020)

Fasting-mimicking diet plus chemotherapy in breast cancer treatment

Claudio Vernieri,
Francesca Ligorio,
Emma Zattarin,
Licia Rivoltini,
Filippo de Braud

Affiliations

Claudio Vernieri: Medical Oncology and Hematology Department, Fondazione IRCCS Istituto Nazionale dei Tumori
Francesca Ligorio: Medical Oncology and Hematology Department, Fondazione IRCCS Istituto Nazionale dei Tumori
Emma Zattarin: Medical Oncology and Hematology Department, Fondazione IRCCS Istituto Nazionale dei Tumori
Licia Rivoltini: Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori
Filippo de Braud: Medical Oncology and Hematology Department, Fondazione IRCCS Istituto Nazionale dei Tumori

DOI: https://doi.org/10.1038/s41467-020-18194-1
Journal volume & issue: Vol. 11, no. 1
pp. 1 – 4

Abstract

Read online

A clinical trial published in Nature Communications examined the effect of fasting-mimicking diet (FMD) during chemotherapy in breast cancer patients. The overall negative study results highlight the need for ameliorating future trial design and investigating alternative FMD-based therapeutic combinations.

Published in Nature Communications

ISSN: 2041-1723 (Online)
Publisher: Nature Portfolio
Country of publisher: United Kingdom
LCC subjects: Science
Website: https://www.nature.com/ncomms/

About the journal